Year 2022 in review – Critical care nephrology

Česká verzia

Authors: J. Chvojka ^1,2,3,4,5; M. Matějovič ^1,2,3
Authors place of work: Jednotka intenzivní péče, I. interní klinika, Lékařská fakulta v Plzni, Univerzita Karlova, Plzeň ¹; Jednotka intenzivní péče, I. interní klinika, Fakultní nemocnice v Plzni ²; Biomedicínské centrum, Lékařská fakulta v Plzni, Univerzita Karlova, Plzeň ³; Klinika anesteziologie, resuscitace a intenzivní medicíny, Lékařská fakulta v Plzni, Univerzita Karlova, Plzeň ⁴; Klinika anesteziologie, resuscitace a intenzivní medicíny, Fakultní nemocnice v Plzni ⁵
Published in the journal: Anest. intenziv. Med., 33, 2022, č. 6, s. 308-311
Category: Review Article
doi: https://doi.org/10.36290/aim.2022.038

Summary

The intensive care medicine literature continued to resonate with the fading COVID-19 pandemic in 2022. Nevertheless, several interesting scientific publications have appeared in the field of critical care nephrology, the contents of which are worth mentioning. This summary article aims to guide the reader through the most fundamental aspects of nephrotoxicity, acute kidney injury, and extracorporeal purification methods.

Keywords:

sepsis – acute kidney injury – nephrotoxicity – extracorporal purification methods

Zdroje

1. Beneš J, Chvojka J, Karvunidis T, Kletečka J, Máca J, Zatloukal, et al. Rok 2021 v přehledu – Intenzivní medicína. Anest intenziv Med. 2021;32(6):271-279.

2. Blair M, Côté JM, Cotter A, Lynch B, Redahan L, Murray PT. Nephrotoxicity from Vancomycin Combined with Piperacillin‑Tazobactam: A Comprehensive Review. Am J Nephrol. 2021;52:85-97. doi: 10.1159/000513742.

3. Li H, Yang Q, Gui M, Ding L, Yang L, Sun H, et al. Changes of renal transporters in the kinetic process of VCM‑ induced nephrotoxicity in mice. Toxicol Res (Camb). 2021;10(4):687- 695. doi:10.1093/toxres/tfab048

4. Miano TA, Hennessy S, Yang W, Dunn TG, Weisman AR, Oniyide O, et al. Association of vancomycin plus piperacillin–tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study. Intensive Care Medicine. 2022;48(9):1144-1155.

5. Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, et al. Effect of therapeutic drug monitoring‑based dose optimization of piperacillin/tazobactam on sepsis‑related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med. 2022;48(3):311-321.

6. Chawla L. Permissive azotemia during acute kidney injury enables more rapid renal recovery and less renal fibrosis: a hypothesis and clinical development plan. Critical Care. 2022;26(1):116.

7. Wald R, Beaubien‑Souligny W, Chanchlani R, Clark EG, Neyra JA, Ostermann M, et al. Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury. Intensive Care Med. 2022;48(10):1368-1381.

8. Murugan R, Bellomo R, Palevsky PM, Kellum JA. Ultrafiltration in critically ill patients treated with kidney replacement therapy. Nat Rev Nephrol. 2021;17(4):262-276.

9. Murugan R, Kerti SJ, Chang CCH, Gallagher M, Neto AS, Clermont G, et al. Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study. Blood Purif. 2021:1-13. doi: 10.1159/000517281.

10. Fah M, Van Althuis LE, Ohnuma T, Winthrop HM, Haines KL, Williams D, et al. Micronutrient deficiencies in critically ill patients receiving continuous renal replacement therapy. Clin Nutr ESPEN. 2022;50:247-254.

11. Thompson Bastin ML, Stromberg AJ, Nerusu SN, Liu LJ, Mayer KP, Liu KD, et al. Association of Phosphate‑Containing versus Phosphate‑Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy. CJASN. 2022;17(5)634-642.

12. Kotfis K, van Diem‑Zaal I, Roberson SW, Sietnicki M, van den Boogaard M, Shehabi Y, et al. The future of intensive care: delirium should no longer be an issue. Crit Care. 2022;26(1):200.

13. Sansom B, Sriram S, Presneill J, Bellomo R. Low Blood Flow Continuous Veno‑Venous Haemodialysis Compared with Higher Blood Flow Continuous Veno‑Venous Haemodiafiltration: Effect on Alarm Rates, Filter Life, and Azotaemic Control. Blood Purif. 2022;51:130- 137. doi: 10.1159/000516146

14. Supady A, Zahn T, Kuhl M, Maier S, Benk Ch, Kaier K, et al. Cytokine adsorption in patients with post‑ cardiac arrest syndrome after extracorporeal cardiopulmonary resuscitation (CYTER) - A single‑ centre, open‑ label, randomised, controlled trial, Resuscitation. 2022;173:169-178.

15. Diab M, Lehman T, Bothe W, Platzer S, Wendt D, Deppe AC, et al. Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial. Circulation. 2022;145:959-968.

16. Stockmann H, Thelen P, Stroben F, Pigorsch M, Keller T, Krannich A, et al. Cytosorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open‑Label, Randomized Controlled Pilot Study. Crit Care Med. 2022;50(6):964-976.